We have successfully fabricated nanocomposite, which is composed of polyaniline (PAni) and pyrene butyric acid (Pyba) via solvent shift method, and the outer layer was enclosed by Tween 80 as a surfactant. First of all, the various ratios between PAni and Pyba were applied for synthesis of polyaniline nanocomposite, and an identical condition for exhibition of proper absorbance and fluorescence properties was found out. The morphology of polyaniline nanocomposite was confirmed via scanning electron microscopic imaging and hydrodynamic size was also confirmed by dynamic light scattering method. We demonstrated that confined self-doped polyaniline nanocomposite as a pH sensing agent are preserved in the doped state even at a neutral pH value. Especially, PAni exhibited strong convertible property at absorbance spectra, on the other hand, Pyba showed changing property at fluorescence spectra at various pH values. In conclude, this polyaniline nanocomposite can accomplish as a fine nanoagent expressing absorbance and fluorescence properties according to surrounding pH values.
Biomarker-specific photothermal nanoparticles that can efficiently sense markers that are overexpressed in distinguished adenocarcinomas have attracted much interest in an aspect of efficacy increase of cancer treatment. We demonstrated a promising prospect of a smart photothermal therapy agent employing anti-epidermal growth factor receptor aptamer (Apt EGFR )-conjugated polyethylene glycol (PEG) layted gold nanorods (Apt EGFR -PGNRs). The cetyltrimethylammonium bromide bilayer on GNRs was replaced with heterobifunctional PEG (COOH-PEG-SH) not only to serve as a biocompatible stabilizer and but also to conjugate Apt EGFR . Subsequently, to direct photothermal therapy agent toward epithelial cancer cells, the carboxylated PEGylated GNRs (PGNRs) were further functionalized with Apt EGFR using carbodiimide chemistry. Then, to assess the potential as biomarker-specific photothermal therapy agent of synthesized Apt EGFR -PGNRs, the optical properties, biocompatibility, colloidal stability, binding affinity, and epicellial cancer cell killing efficacy in vitro/in vivo under near-infrared laser irradiation were investigated. As a result, Apt EGFR -PGNRs exhibit excellent tumor targeting ability and feasibility of effective photothermal ablation cancer therapy.
In this study, we describe the development of a cancer biomarker-sensitive nanobiosensor based on localized surface plasmon resonance that enables recognition for proteolytic activity of membrane type 1 matrix metalloproteinase (MT1-MMP) anchored on invasive cancer cells. First of all, we prepared biomarker-detectable substrate based on gold nanorods (GNRs) using nanoparticle adsorption method. The sensitivity of the sensing chip was confirmed using various solvents that have different refractive indexes. Subsequently, MT1-MMP–specific cleavable peptide was conjugated onto the surface of GNRs, and molecular sensing about proteolytic activity was conducted using MT1-MMP and cell lysates. Collectively, we developed a biomarker detectable sensor, which allows for the effective detection of proteolytic activity about MT1-MMP extracted from invasive cancer cells.
In this study, we describe the development of cancer biomarker-sensitive nanobiosensor based on localized surface
plasmon resonance (LSPR) that enabling recognition for proteolytic activity of membrane type 1 matrix metalloproteinase (MT1-MMP) anchored on invasive cancer cells. First of all, we prepared biomarker-detectable substrate based on gold nanorods (GNRs) using nanoparticle adsorption method. The sensitivity of sensing chip was confirmed using various solvents that having different refractive indexes. Subsequently, MT1-MMP-specific cleavable
peptide was conjugated onto surface of GNRs and molecular sensing about proteolytic activity was conducted using MT1-MMP and cell lysates. Collectively, we developed biomarker detectable sensor, which allows for the effective detection of proteolytic activity about MT1-MMP extracted from invasive cancer cells.
Biomarker-specific photothermal nanoparticles that can efficiently sense the markers, which are overexpressed in
distinguished adenocarcinomas, has attracted much interest in an aspect of efficacy increase of cancer treatment. In this
study, we demonstrated a promising prospect of smart photothermal therapy agent employing anti-epidermal growth
factor receptor aptamer (AptEGFR)-conjugated polyethylene glycol (PEG)layted gold nanorods (AptEGFR-PGNRs). The
cetyltrimethylammonium bromide bilayer on GNRs was replaced with heterobifunctional polyethylene glycol (COOHPEG-
SH) not only to serve as a biocompatible stabilizer and but also to conjugate AptEGFR. Subsequently, to direct
photothermal therapy agent toward epithelial cancer cells, the carboxylated PEGylated GNRs (PGNRs) were further
functionalized with AptEGFR using carbodiimide chemistry. And then, to assess the potential as biomarker-specific
photothermal therapy agent of synthesized AptEGFR-PGNRs, the optical properties, biocompatibility, colloidal stability,
binding affinity and epicellial cancer cell killing efficacy in vitro/in vivo under NIR laser irradiation were investigated.
As a results, AptEGFR-PGNRs exhibit excellent tumor targeting ability and feasibility of effective photothermal ablation
cancer therapy.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.